BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2009
View Archived Issues
Longer vaccination interval with recombinant malaria vaccine leads to higher immunogenicity
Read More
Losartan a possible therapy for AGTR1-overexpressing breast cancer
Read More
Prasugrel reduces several types of myocardial infarction in TRITON-TIMI 38 trial
Read More
Phenylbutyrate a potential treatment for Alzheimer's disease
Read More
Merrimack initiates dosing in phase I/II clinical study of MM-111 in cancer
Read More
FDA approves Hyperion's SPA for phase III clinical trial of HPN-100 in adults with UCD
Read More
NovaBiotics receives clearance to initiate first-in-man clinical trials of Novexatin
Read More
Kuros initiates treatment in phase IIb clinical trial of KUR-211 in diabetic foot ulcers
Read More
DermaGen completes patient enrollment in phase I/IIa trial of antimicrobial peptide DPK-060
Read More
Bayer submits NDA to FDA for oral contraceptive estradiol valerate/dienogest
Read More
Japanese MHLW approves Novartis' Rasilez for high blood pressure
Read More
Pluristem begins enrollment for phase I clinical trial of PLX-PAD in critical limb ischemia
Read More
ARYx Therapeutics reports results from EmbraceAC phase II/III clinical trial of tecarfarin
Read More
Avanir completes enrollment in open-label extension of phase III STAR trial of Zenvia
Read More
Ikaria obtains worldwide exclusive license to BioLineRx's BL-1040 for AMI
Read More
Peplin completes enrollment in phase III trials of PEP-005 for actinic keratoses
Read More
Daiichi Sankyo launches new formulations of antibacterial agent Cravit in Japan
Read More
Cell Therapeutics to meet with EMEA in September 2009 to discuss MAA for Opaxio
Read More
Shire files treatment protocol with FDA for velaglucerase alfa for Gaucher disease
Read More
Univ. California, Clear Vascular patent peptides for the treatment of vascular plaques
Read More
Novel cannabinoid CB2 receptor ligands patented by Ipsen Pharma
Read More
Hameln rds describes novel ACAT inhibitors for the treatment of lipoprotein disorders
Read More
GlaxoSmithKline describes dual histamine H1 and H3 receptor antagonists
Read More
Novel inhibitor may allow physiological understanding of fatty acid elongase 6
Read More
Wyeth's Enbrel approved in Japan for juvenile idiopathic arthritis indication
Read More
Thallion suspends enrollment for phase II trial of TLN-232 due to dispute with licensor
Read More